Compare EPAC & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EPAC | LMAT |
|---|---|---|
| Founded | 1910 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.9B |
| IPO Year | 1994 | 2006 |
| Metric | EPAC | LMAT |
|---|---|---|
| Price | $39.68 | $78.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | $54.00 | ★ $99.29 |
| AVG Volume (30 Days) | ★ 514.9K | 256.3K |
| Earning Date | 12-16-2026 | 11-04-2026 |
| Dividend Yield | 0.10% | ★ 1.26% |
| EPS Growth | 1.18 | ★ 30.57 |
| EPS | 1.72 | ★ 2.07 |
| Revenue | ★ $652,300,000.00 | $249,602,000.00 |
| Revenue This Year | $27.50 | $10.59 |
| Revenue Next Year | $8.27 | $9.93 |
| P/E Ratio | ★ $22.99 | $38.28 |
| Revenue Growth | 5.74 | ★ 13.53 |
| 52 Week Low | $32.35 | $78.22 |
| 52 Week High | $43.97 | $118.01 |
| Indicator | EPAC | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 56.07 | 43.43 |
| Support Level | $33.82 | $78.35 |
| Resistance Level | $43.93 | $83.68 |
| Average True Range (ATR) | 1.75 | 2.90 |
| MACD | 0.10 | -0.52 |
| Stochastic Oscillator | 52.13 | 5.35 |
Enerpac Tool Group Corp is an industrial tools, services, technology, and solutions provider serving diverse customers and end markets for mission-critical applications. It designs, manufactures, and distributes branded hydraulic and mechanical tools and provides services and tool rental. Its products include branded tools, cylinders, pumps, hydraulic torque wrenches, engineered heavy lifting technology solutions, and other tools. Its single reportable segment is Industrial Tools & Services (IT&S), serving the general industrial, refining and petrochemical, industrial maintenance, repair and operations (MRO), machining and manufacturing, power generation, infrastructure, mining and other markets. The company generates maximum revenue from the United States of America.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.